FDA approves Bristol-Myers drug combination for skin cancer
Permalink

FDA approves Bristol-Myers drug combination for skin cancer

Leonard Saltz of Memorial Sloan Kettering Cancer Center, who estimated earlier this year that the…

Continue Reading →